Sanolium AB (publ) (the “Company“) has on 10 May 2022 issued subsequent senior secured bonds, in an amount of SEK 300,000,000, within a total framework amount of SEK 1,000,000,000, with ISIN SE0012596179 (the “Subsequent Bonds“).

The Company will apply for listing of the Subsequent Bonds on the Corporate Bond list at Nasdaq Stockholm. The Subsequent Bonds will be admitted to trading at Nasdaq Stockholm as soon as possible.

In connection with this, the Company has prepared a prospectus. The prospectus has been approved by, and registered with, the Swedish Financial Supervisory Authority in accordance with Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017. The prospectus will be available on the Financial Supervisory Authority’s website (www.fi.se) and on the Company’s website (www.cambiogroup.com).

This information is information that Sanolium AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at [time] CEST on 20 May 2022.

For further information, please contact:

Niklas Berglund

Chief Financial Operator

Tel.: +46(8) 691 49 00

Email: niklas.berglund@cambio.se